about
Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery diseaseAdiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: the epidemiologic data on the insulin resistance syndrome prospective study.The PPARG Pro12Ala polymorphism is associated with a decreased risk of developing hyperglycemia over 6 years and combines with the effect of the APM1 G-11391A single nucleotide polymorphism: the Data From an Epidemiological Study on the Insulin ResiFerritin and transferrin are both predictive of the onset of hyperglycemia in men and women over 3 years: the data from an epidemiological study on the Insulin Resistance Syndrome (DESIR) study.Ferritin and transferrin are associated with metabolic syndrome abnormalities and their change over time in a general population: Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR).Predicting diabetes: clinical, biological, and genetic approaches: data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR).Genetic variability at the six transmembrane protein of prostate 2 locus and the metabolic syndrome: the data from an epidemiological study on the Insulin Resistance Syndrome (DESIR) study.Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. studyManganese superoxide dismutase (SOD2) polymorphisms, plasma advanced oxidation protein products (AOPP) concentration and risk of kidney complications in subjects with type 1 diabetes.Adiponectin gene variants, adiponectin isoforms and cardiometabolic risk in type 2 diabetic patients.Decreased insulin secretion and increased risk of type 2 diabetes associated with allelic variations of the WFS1 gene: the Data from Epidemiological Study on the Insulin Resistance Syndrome (DESIR) prospective study.Dairy consumption and the incidence of hyperglycemia and the metabolic syndrome: results from a french prospective study, Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR).GUESS-ing polygenic associations with multiple phenotypes using a GPU-based evolutionary stochastic search algorithm.Plasma extracellular superoxide dismutase concentration, allelic variations in the SOD3 gene and risk of myocardial infarction and all-cause mortality in people with type 1 and type 2 diabetesNew loci for body fat percentage reveal link between adiposity and cardiometabolic disease riskAdiponectin gene and cardiovascular risk in type 2 diabetic patients: a review of evidences.Prognostic value of the insertion/deletion polymorphism of the ACE gene in type 2 diabetic subjects: results from the Non-insulin-dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR), DiaPlasma Copeptin, AVP Gene Variants, and Incidence of Type 2 Diabetes in a Cohort From the Community.Plasma copeptin and renal outcomes in patients with type 2 diabetes and albuminuria.Urinary Sodium Concentration Is an Independent Predictor of All-Cause and Cardiovascular Mortality in a Type 2 Diabetes Cohort Population.Interindividual variability in the cholesterol-lowering effect of supplementation with plant sterols or stanols.Plasma Copeptin, Kidney Outcomes, Ischemic Heart Disease, and All-Cause Mortality in People With Long-standing Type 1 Diabetes.Longitudinal association of antidepressant medication use with metabolic syndrome: Results of a 9-year follow-up of the D.E.S.I.R. cohort study.Antidepressant medication use and trajectories of fasting plasma glucose, glycated haemoglobin, β-cell function and insulin sensitivity: a 9-year longitudinal study of the D.E.S.I.R. cohort.T-cadherin gene variants are associated with type 2 diabetes and the Fatty Liver Index in the French population.Dynamic Changes in Renal Function Are Associated With Major Cardiovascular Events in Patients With Type 2 Diabetes.Interaction between GPR120 p.R270H loss-of-function variant and dietary fat intake on incident type 2 diabetes risk in the D.E.S.I.R. study.The loss-of-function PCSK9 p.R46L genetic variant does not alter glucose homeostasis.Plasma Adrenomedullin and Allelic Variation in the ADM Gene and Kidney Disease in People With Type 2 Diabetes.Death, end-stage renal disease and renal function decline in patients with diabetic nephropathy in French cohorts of type 1 and type 2 diabetes.Plasma Copeptin and Decline in Renal Function in a Cohort from the Community: The Prospective D.E.S.I.R. Study.HLA and longevity.Potential risks associated with increased plasma plant-sterol levels.Contribution of the low-frequency, loss-of-function p.R270H mutation in FFAR4 (GPR120) to increased fasting plasma glucose levels.Comment on: Park et al. Association of serum ferritin and the development of metabolic syndrome in middle-aged Korean men: a 5-year follow-up study. Diabetes Care 2012;35:2521-2526.The functional c.-2G>C variant of the mineralocorticoid receptor modulates blood pressure, renin, and aldosterone levels.Associations of the -344 T>C and the 3097 G>A polymorphisms of CYP11B2 gene with hypertension, type 2 diabetes, and metabolic syndrome in a French population.Association of ADIPOQ genetic variants and plasma adiponectin isoforms with the risk of incident renal events in type 2 diabetes.Adiponectin multimers and ADIPOQ T45G in coronary artery disease in Caribbean type 2 diabetic subjects of African descent.Association of a functional 5-HT transporter gene polymorphism with anorexia nervosa and food intake.
P50
Q28206251-0E4F23B6-5378-4240-A409-A14C9087ADCBQ30916927-8B96B9FE-E658-426E-8045-9FADAAE6FF55Q31035230-1808AEEE-1185-4589-9760-09B63E3482FBQ31057231-DA219832-B0B0-456F-AE8C-2645B6783B9AQ31108465-EC659596-1EAF-4EB8-A0F2-11460502272FQ31170360-E6707A4C-216A-4C59-8891-8D66CAE5A169Q33552026-465230CE-8DC7-40EB-80D7-E076E78E6369Q33596744-13C208FB-503A-4F53-AB5A-8067871B406DQ33599793-81822322-74FC-459C-840D-58AD878A473EQ33622255-F0902810-1241-4ED9-93EC-DCFA74135407Q33762350-F5EAEA16-9F46-4B9A-92A0-7592DA0B38DAQ33857397-AA416B9E-AE6E-4F03-B584-11B63D741767Q34945566-0826CDE7-0F5F-47B1-8E71-D2645D646E57Q35073993-ECC844BC-B8E8-46DE-A1A6-A848F006BF82Q36541220-B95A70F1-01D8-4C40-AA04-29D4E5D8E4D8Q36823761-330C1C12-FB8F-45B7-8127-AE3A55BBEF53Q36842087-74988896-6671-46C9-BC56-5321686A9BA0Q36965316-FEC92C3A-552A-400D-9467-212B03D800F6Q37278044-716FD40A-9E37-4CD2-877C-1E284301AA78Q37642298-046250F5-1DE9-4215-9252-B4114B21CD30Q38980512-29088515-428B-4F59-886D-861591312586Q39301615-0C5A66C3-629C-4292-BF9E-1F7542092248Q39448035-D0FDE059-8BA3-4949-8C3C-129EBF0C8A6AQ40657746-7B10B6D5-C6F3-42CF-9B9D-F40F867ACCC2Q40706413-3FF5B658-5FEA-4492-9EDD-A402778E5A9AQ40736863-0A8D751F-2F74-4C75-85FB-33F4EBEF696DQ40741672-CB61FDFA-62EB-48EA-966E-157090B2A36AQ40863199-5333DE33-6E8D-476C-B76D-31E7375A61E1Q40967493-24DE2E8A-00B2-414E-80D9-5BA70E8F8999Q41198632-1CDBCCB2-1AED-44A6-A9AD-1930FFBF12C4Q41394637-25E3F6F2-F1AA-4AB9-BC5D-3936825A0FEEQ41622181-DCBAFA62-9BFF-4D98-B58D-FD8C8CF444CDQ41701575-04D2571D-506C-47D5-9615-F774BDA41C18Q41707994-ECEF5747-5E43-4DA5-80BA-F1F0D30AD35CQ42357808-DFFDDE5B-7061-42FB-900B-6834B372108DQ42882474-7BA7873E-18B0-4AD6-91C3-2059F4CE138FQ43132423-5B3213F9-84A6-41FE-B798-7F972483F3BCQ43190717-A21AD02D-7FB2-4D77-8FA6-51ABF4A7AC3BQ43230203-9CA79249-830B-492F-98CE-FBE7EEAA4858Q43539788-FCBBD5FF-7EBC-47F9-9696-1098EEB46C24
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Frédéric Fumeron
@ast
Frédéric Fumeron
@en
Frédéric Fumeron
@es
Frédéric Fumeron
@nl
Frédéric Fumeron
@sl
type
label
Frédéric Fumeron
@ast
Frédéric Fumeron
@en
Frédéric Fumeron
@es
Frédéric Fumeron
@nl
Frédéric Fumeron
@sl
altLabel
Frederic Fumeron
@en
prefLabel
Frédéric Fumeron
@ast
Frédéric Fumeron
@en
Frédéric Fumeron
@es
Frédéric Fumeron
@nl
Frédéric Fumeron
@sl
P214
P106
P1153
7003436922
P21
P213
0000 0003 5837 1376
P214
P31
P496
0000-0002-7916-4619
P735
P7859
viaf-206109545